PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达
Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis

DOI: 10.6040/j.issn.1671-7554.0.2017.072

Keywords: 子宫腺肌病,上皮-间质转化,聚腺苷二磷酸核糖聚合酶-1,E-钙黏蛋白,波形蛋白,Snail,
Adenomyosis,Snail,Epithial-mesenchymal transition,Poly(ADP-ribose)polymerase-1,E-cadherin,Vimentin

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	吕树卿, 尉蔚, 张灿灿, 等. HGF/PARP-1 信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报(医学版), 2015, 53(7): 1-7. L(¨overU)Shuqing,WEI Wei,ZHANG Cancan,et al. Mechanism of HGF /PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer[J]. Journal of Shandong University(Health Sciences), 2015, 53(7): 1-7.
[2]	冷金花, 郎景和. 子宫腺肌病的手术治疗[J]. 实用妇产科杂志, 2006, 22(1): 10-12.
[3]	Garavaglia E, Audrey S, Annalisa I, et al. Adenomyosis and its impact on women fertility[J]. Iran J Reprod Med, 2015, 13(6): 327-336.
[4]	Chen YJ, Li HY, Huang CH, et al. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis[J]. J Pathol, 2010, 222(3): 261-270.
[5]	张灿灿,尉蔚,林雪艳,等. 上皮性卵巢癌中 PARP-1 的表达及其与EMT的关系[J]. 中国病理生理杂志, 2016, 32(3): 425-431. ZHANG Cancan, WEI Wei, LIN Xueyan, et al. Expression of PARP-1 in epithelial ovarian cancer and its relationship with epithelial-mesenchymal transition[J]. Chin J Pathophys, 2016, 32(3): 425-431.
[6]	Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair[J]. Arch Gynecol Obstet, 2009, 280(4): 529-538.
[7]	An M, Li D, Yuan M, et al. Interaction of macrophages and endometrial cells induces epithelial-mesenchymal transition-like processes in adenomyosis?[J]. Biol Reprod, 2017, 96(1): 46.
[8]	孙丹, 孙成刚, 王峰, 等. 肝细胞肝癌组织Snail mRNA和蛋白的表达[J]. 山东大学学报(医学版), 2010, 48(4): 70-73. SUN Dan, SUN Chenggang, WANG Feng, et al. Expressions of Snail mRNA and protein in hepatocellular carcinoma[J]. Journal of Shandong University(Health Sciences), 2010, 48(4): 70-73.
[9]	Wang Z, Li Y, Lv S, et al. Inhibition of proliferation and invasiveness of ovarian cancer C13<sup>*</sup> cells by a poly(ADP-ribose)polymerase inhibitor and the role of nuclear factor-ΚB[J]. J Int Med Res, 2013, 41(5):1577-1585.
[10]	Oh SJ, Shin JH, Kim TH, et al. β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition[J]. J Pathol,2013, 231(2): 210-222.
[11]	Robu M, Shah RG, Petitclerc N, et al. Role of poly(ADP-ribose)polymerase-1 in the removal of UV-induced DNA lesions by nucleotide excision repair[J]. Proc Natl Acad Sci U S A, 2013, 110(5): 1658-1663.
[12]	Bai P, Virág L. Role of poly(ADP-ribose)polymerases in the regulation of inflammatory processes[J]. FEBS Lett, 2012, 586(21): 3771-3777.
[13]	Jiang BH, Tseng WL, Li HY, et al. Poly(ADP-ribose)polymerase 1: cellular pluripotency, reprogramming, and tumorogenesis[J]. Int J Mol Sci, 2015, 16(7): 15531-15545.
[14]	Rodríguez MI, Peralta-Leal A, Ovalle F, et al. PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation[J]. PLoS Genet, 2013, 9(6): e1003531. doi: 10.1371/journal.pgen.1003531.
[15]	Goulooze SC, Cohen AF, Rissmann R. Olaparib[J].Br J Clin Pharmacol, 2016, 81(1):171-173.
[16]	McPhee TR, McDonald PC, Oloumi A, et al. Integrin-linked kinase regulates E-cadherin expression through PARP-1[J]. Dev Dyn, 2008, 237(10): 2737-2747.
[17]	Matsuzaki S, Darcha C. Epithelial to mesenchymal transition-like and mesenchymal to epithelial transition-like processes might be involved in the pathogenesis of pelvic endometriosis[J]. Hum Reprod, 2012, 27(3):712-721.
[18]	Proestling K, Birner P, Gamperl S, et al. Enhanced epithelial to mesenchymal transition(EMT)and upregulated MYC in ectopic lesions contribute independently to endometriosis[J]. Reprod Biol Endocrinol, 2015, 13(1): 1-11.
[19]	Qi S, Zhao X, Li M, et al. Aberrant expression of Notch1/numb/snail signaling, an epithelial mesenchymal transition related pathway, in adenomyosis[J]. Reprod Biol Endocrinol, 2015, 13(1): 1-10.
[20]	Song IO, Hong SR, Huh Y, et al. Expression of vimentin and cytokeratin in eutopic and ectopic endometrium of women with adenomyosis and ovarian endometrioma[J]. Am J Reprod Immunol, 1998, 40(1): 26-31.
[21]	Lu MH, Fan MF, Yu XD. NSD2 promotes osteosarcoma cell proliferation and metastasis by inhibiting E-cadherin expression[J].Eur Rev Med Pharmacol Sci, 2017, 21: 928-936.
[22]	Zhu Y, Zhang Y, Sui Z, et al. USP14 de-ubiquitinates vimentin and miR-320a modulates USP14 and vimentin to contribute to malignancy in gastric cancer cells[J]. Oncotarget, 2016. doi: 10.18632/oncotarget.10706.
[23]	García S, Conde C. The role of poly(ADP-ribose)polymerase-1 in rheumatoid arthritis[J]. Mediators Inflamm, 2015;2015:837250. doi: 10.1155/2015/837250.
[24]	Kanai Y. Overview on poly(ADP-ribose)immuno-biomedicine and future prospects[J]. Proc Jpn Acad Ser B Phys Biol Sci, 2016, 92(7): 222-236.
[25]	Zhang J, Kan Y, Tian Y, et al. Effects of poly(ADP-ribosyl)polymerase(PARP)inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13<sup>*</sup> cells[J]. Indian J Med Res, 2013, 137(3): 527-532.

Full-Text